bioworld.com

GENERAL
META
HTML
LINK ANALYSIS
SERVER
IP

Bioworld.com receives any estimated 4,410 unique visitors and 8,476 unique page views per day. Revenue gained from these much visits may be $13 per day from various advertising sources. The estimated worth of site is $9,596. Alexa global rank is 296,876. Maximum no. of users comes from CHINA. Rank in CHINA is 35,027.

NSI Hosting is ISP, hosted on IP 208.91.60.34 in Country United States.

Website Age n/a
Alexa Rank no-data
Country United States
IP Address 208.91.60.34

META INFORMATION

Title

BioWorld: The Daily Biopharmaceutical and Medical Technology News Source

Description

Daily news and analysis of the global biotechnology, pharmaceutical and medical technology industries.

Keywords

news, analysis, biotech, biotechnology, pharma, pharmaceutical, health, business, medtech, medical technology, devices, diagnostics, financing, regulation, science, innovation, drug approvals, FDA, EMA, clinical trials, partners***ps, collaborations

Content Type

No	Meta Name	Value
1	viewport	width=device-width, initial-scale=1.0

KEYWORDS AND KEYWORD DENSITY

No	Keyword	Website Count
1	News	550
2	Analysis	31
3	Biotech	6
4	Biotechnology	12
5	Pharma	9
6	Pharmaceutical	6
7	Health	131
8	Business	221
9	Devices	5
10	Diagnostics	3
11	Financing	16
12	Regulation	6
13	Science	106
14	İnnovation	46
15	Fda	4
16	Clinical trials	8
17	Partners***ps	2

google ads

GENERAL HTML INFORMATION

Type	Status
HTML 5
Responsive Website

HTML SIZE INFORMATION

Text / Code Ratio 7.18 %

bioworld.com has a website text/code ratio of 7.18 %. Search engine crawlers tend to not pick up pages with inadequate content.

IMPORTANT HTML TAGS AND COUNTS

Titles

H135
H20
H30
H40
H50
H60

No	Text
1	Bioworld. link to homepage. (2)
2	Bioworld
3	Genmab banks $750m up front in $3.9b oncology alliance with abbvie
4	Bıo digital: covıd-19 vaccines outlook offers reasons for hope, concern
5	Public-private partners***ps key to development of new alzheimer’s disease therapies
6	Checkmate lands $85m series c to continue tlr9 wars
7	Opthea’s opt-302 meets primary endpoints in phase ııa diabetic macular edema trial
8	Today's news in brief (2)
9	Canbridge moves to expand rare disease pipeline with uma*** collaboration
10	Senator: now’s the time to plan for next pandemic
11	ındia posts draft rules for compa***ionate use of unapproved drugs
12	Astellas reports positive results for roxadustat phase ııı study
13	Bioworld medtech
14	Gtx medical receives breakthrough device designation for implanted spinal stimulation system
15	Beijing export officials using black, whitelists to determine exportability of test kits
16	California startup secures $100m for rapid diagnostic platform
17	C2i genomics raises $12m series a to bring whole genome pattern recognition to liquid biopsy
18	Bioworld medtech’s orthopedics extra for june 10, 2020
19	Cerevasc raises $43.9m to advance hydrocephalus treatment
20	Feinstein ınst**utes research demonstrates next step in bioelectronic medicine
21	U.s. federal government eyes private sector role in strategic stockpile management
22	Johns hopkins cryoablation study could boost procedure to first-line in early kidney cancer
23	Bioworld asia
24	ınnovent partners with roche in multibillion-dollar deal targeting bispecifics, cell therapies
25	Australia’s csl builds out its transplant franchise with acquisition of canadian biotech vitaeris
26	Legend leads active day for nasdaq biopharma ıpos
27	Asia-focused everest medicines closes $310m series c financing round
28	Shanghai startup eccogene bets on small molecules for nash
29	Chi-med and beigene partner up to test candidates in combination therapy
30	Beigene’s fda-cleared btk inhibitor brukinsa approved in china
31	Bıo digital: ındustry looks for collaboration, recognition in covıd-19 efforts
32	News in brief
33	Csl, university of queensland partner with cepı to bring covıd-19 vaccine to the clinic

Text Styling

STRONG0
B0
EM0
I0
U0
CITE0

LINK ANALYSIS

Total Link Count: 114

Internal Link Count : 103

No	Text	Type
1	BioWorld	text
2	BioWorld MedTech	text
3	BioWorld Asia	text
4	Data Snapshots	text
5	Special reports	text
6	Artificial intelligence	text
7	Coronavirus	text
8	Diagnosing the state of COVID-19 testing	text
9	Drugs to Watch 2020	text
10	The next pandemic	text
11	Premium reports	text
12	BioWorld Financings Reports	text
13	Disease Forecast Reports	text
14	-	empty
15	BioWorld. Link to homepage.	text
16	-	empty
17	Sign In	text
18	Create Account	text
19	Sign Out	text
20	My Account	text
21	Subscribe	text
22	-	empty
23	BioWorld	text
24	BioWorld MedTech	text
25	BioWorld Asia	text
26	BioWorld	text
27	-	image
28	Genmab banks $750M up front in $3.9B oncology alliance with Abbvie	text
29	BIO Digital: COVID-19 vaccines outlook offers reasons for hope, concern	text
30	Public-private partners***ps key to development of new Alzheimer’s disease therapies	text
31	Checkmate lands $85M series C to continue TLR9 wars	text
32	Opthea’s OPT-302 meets primary endpoints in phase IIa diabetic macular edema trial	text
33	Today's news in brief	text
34	Canbridge moves to expand rare disease pipeline with UMa*** collaboration	text
35	Senator: Now’s the time to plan for next pandemic	text
36	India posts draft rules for compa***ionate use of unapproved drugs	text
37	Astellas reports positive results for roxadustat phase III study	text
38	More in BioWorld	text
39	BioWorld MedTech	text
40	-	image
41	Gtx Medical receives breakthrough device designation for implanted spinal stimulation system	text
42	Beijing export officials using black, whitelists to determine exportability of test kits	text
43	California startup secures $100M for rapid diagnostic platform	text
44	Today's news in brief	text
45	C2i Genomics raises $12M series A to bring whole genome pattern recognition to liquid biopsy	text
46	BioWorld MedTech’s Orthopedics Extra for June 10, 2020	text
47	Cerevasc raises $43.9M to advance hydrocephalus treatment	text
48	Feinstein Inst**utes research demonstrates next step in bioelectronic medicine	text
49	U.S. federal government eyes private sector role in strategic stockpile management	text
50	Johns Hopkins cryoablation study could boost procedure to first-line in early kidney cancer	text

External Link Count : 11

No	Text	Type
1	More information on our cookie policy.	text
2	Powering insights from Cortellis. Link to Cortellis page on Clarivate website.	text
3	-	image
4	-	image
5	Contact us	text
6	Cookie policy	text
7	Copyright notice	text
8	Privacy policy	text
9	Terms of use	text
10	A Clarivate Analytic solution. Link to Clarivate website.	text
11	ePublis***ng	text

Nofollow Link Count : 0

Title Link Count : 0

WEBSITE SERVER INFORMATION

Service Provider (ISP)
NSI Hosting
Hosted IP Address
208.91.60.34
Hosted Country
United States
Host Region
Virginia , Ashburn
Latitude and Longitude
39.0438 : -77.4874

WEBSITES USING THE SAME C CLASS IP

Icon	Domain	IP	Alexa Rank
	Enr.com	208.91.60.101	80.870
	Sdmmag.com	208.91.60.115	352.616
	a***emblymag.com	208.91.60.124	265.465
	Ishn.com	208.91.60.132	224.829
	Qualitymag.com	208.91.60.138	143.565
	Securitymagazine.com	208.91.60.140	92.544
	Wattagnet.com	208.91.60.169	209.602
	Labusinessjournal.com	208.91.60.171	117.309
	Naturalgasintel.com	208.91.60.44	224.883
	Safetyandhealthmagazine.com	208.91.60.45	171.996
	Dcvelocity.com	208.91.60.47	182.056
	Premierguitar.com	208.91.60.49	68.780
	World-Grain.com	208.91.60.81	294.025
	Supplychainbrain.com	208.91.60.84	161.909
	Foodbusinessnews.net	208.91.60.86	107.922

COUNTRIES More

Last Updated Websites

Last viewed websites

google ads

LASTEST ANALYZED WEBSITES

HOW DO I REMOVE MY WEBSITE ?

REPORT THIS WEBSITE

Website Analysis

SHARE THIS ANALYSIS

Analyzing...